Brain Stimulation for Stroke Recovery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if two non-invasive techniques can enhance recovery after a stroke. One method, BCI-FES (Brain-Computer Interface-Controlled Functional Electrical Stimulation), stimulates arm muscles, while the other uses the tongue to send signals to the brain. Participants include individuals with ongoing arm movement issues due to a stroke, those at risk of stroke, and healthy individuals. The researchers hope to discover if these new methods surpass current treatments in effectiveness. As an unphased trial, this study provides participants the chance to contribute to groundbreaking research that could lead to new stroke recovery methods.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that these brain stimulation techniques are safe for stroke recovery?
Research has shown that both BCI-FES and RecoveriX treatments are safe for stroke survivors. Studies on BCI-FES indicate it can improve arm movement without major side effects. Similarly, RecoveriX has proven effective and safe, with no serious safety issues reported. Both treatments use the brain's signals to activate muscles and restore movement. Patients have tolerated these methods well, suggesting they are safe options for stroke recovery.12345
Why are researchers excited about this trial's treatments?
Researchers are excited about these treatments for stroke recovery because they combine brain-computer interface (BCI) and functional electrical stimulation (FES) in innovative ways. Unlike traditional physical therapy, which often relies on repetitive movement exercises, BCI-FES and RecoveriX directly engage the brain's neural pathways. BCI-FES uses a closed-loop EEG system to help retrain the brain by linking thought to movement, potentially speeding up recovery. RecoveriX takes this a step further by merging virtual reality with BCI technology, creating a fully immersive rehabilitation experience. These approaches offer hope for more effective and faster recovery compared to standard therapies.
What evidence suggests that this trial's treatments could be effective for stroke recovery?
Research has shown that BCI-FES, which combines brain-computer interface technology with electrical stimulation, can aid stroke recovery by improving arm movement. Studies indicate that it provides immediate benefits for stroke survivors, enhancing arm mobility. Some participants in this trial will receive immediate BCI therapy, while others will receive delayed BCI therapy, both aiming to assess the effectiveness of BCI-FES in stroke recovery.
RecoveriX, another brain-computer interface system under study in this trial, has shown promising results in improving movement and reducing muscle stiffness in stroke patients. In one study, 51 participants experienced significant improvements in arm movement. This suggests that RecoveriX may effectively aid stroke recovery by enhancing arm function.15678Who Is on the Research Team?
Vivek Prabhakaran, MD, PhD
Principal Investigator
University of Wisconsin, Madison
Are You a Good Fit for This Trial?
This trial is for stroke survivors with moderate arm impairment, who were independent before their stroke. It's not for those allergic to electrode gel or metals, pregnant women, people with MRI contraindications, infectious diseases, or oral lesions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Assessment
Participants undergo pre-intervention MRI and behavioral testing
Treatment
Participants receive EEG-BCI training with muscle and tongue stimulation
Follow-up
Participants are monitored for changes in EEG/fMRI and behavioral measures
What Are the Treatments Tested in This Trial?
Interventions
- BCI-FES
- RecoveriX
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Madison
Lead Sponsor
American Heart Association
Collaborator